Clinical Trial Update: Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Infusion Laboratory: Protocol 5 using flupenthixol in cocaine-related disorders; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cocaine-related Disorders

Drugs mentioned

• Flupenthixol (flupenthixol)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cocaine-Related Disorders | Phase 1 | Status: UNKNOWN